Full-Service CRO Eurotrials Opens New Office In Mexico
LISBON, PORTUGAL, FEBRUARY 22 2016 – Eurotrials, a clinical research organization (CRO) specialized in Europe and Latin America, is pleased to announce the opening of its new office in Mexico City, Mexico. The new office strengthens the company’s presence in Latin America and further boosts its growth and expansion, providing full operational coverage in this key emergent region.
Hector De Lille, MD, Project Manager, will head the new office. Hector has over 12 years of experience in the clinical research area, and is a specialist in Clinical Studies Management in Latin America. “This investment demonstrates Eurotrials’ confidence in the clinical research field in Mexico, one of the most important markets for clinical research today, where several strategic decisions are being taken towards positive development. This will consolidate Eurotrials’ position as a key player in Latin America” said Hector.
Maria João Queiroz, Global CEO at Eurotrials, explains the latest addition in Eurotrials family: ”Eurotrials continues to grow successfully and sustainably as a result of our unique commitment to deliver our clients’ needs on time, on budget and to the highest quality. The office will support the growth of the company’s global business, which helps pharmaceutical, biotechnology and medical device companies bring new therapies and treatments to the market.”
Located in Mexico City centre, the new office is one of its main six sites – including Brazil, Argentina, Chile, Portugal and Spain - dedicated to Eurotrials full-service CRO operations, reinforcing its position and capabilities in all LATAM region. The Mexico-based office specializes in strategic consulting, clinical studies conduct, project management and outcome research. The team helps pharmaceutical and biotechnology partners develop strategic plans for the entire drug development process.
About Eurotrials
Eurotrials is a full-service CRO focused in Europe and Latin America with strong local expertise. The company has been validated by international biopharmaceutical companies, has several master agreements and is ISO- 9001 certified. With more than 20 years of experience, Eurotrials has offices in Mexico, Brazil, Argentina, Chile, Portugal and Spain, covering over 15 countries in both regions. Eurotrials provides an extensive array of services from early- to late-stage research as well as product support in accordance with global and specific regional requirements.
You can visit Eurotrials at the website http://www.eurotrials.com; Twitter: @Eurotrials
Roche’s Susvimo Lands FDA Approval for Diabetic Retinopathy Based on Phase III Pavilion Trial Data
May 22nd 2025One-year results from the Pavilion study showed patients who received Susvimo (ranibizumab) refilled every nine months achieved superior improvements on the Diabetic Retinopathy Severity Scale.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Outlines Updated Requirement for Placebo-Controlled Trials in Vaccine Research
May 21st 2025In an article recently published by The New England Journal of Medicine, FDA higher-ups Vinay Prasad, MD, MPH; and Martin A. Makary, MD, MPH, wrote that any new COVID-19 vaccine must now be evaluated in placebo-controlled studies.
